John Koconis Timber Pharmaceuticals, Inc. (TMBR) insider trading activity

TMBR Quotes by TradingView

John Koconis is CEO & Chairman of Timber Pharmaceuticals, Inc.. Currently has a direct ownership of 70,785 shares of TMBR, which is worth approximately $0. The most recent transaction as insider was on Aug 20, 2023, when has been sold 70,385 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.8K
0% 3M change
0% 12M change
Total Value Held $0

John Koconis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2023
BUY
Grant, award, or other acquisition
-
70,385 Added 49.86%
70,785 Common Stock, par valu...
Dec 15 2021
BUY
Open market or private purchase
$7,600 $0.38 p/Share
20,000 Added 50.0%
20,000 Common Stock, par valu...
JK

John Koconis

CEO & Chairman
Basking Ridge, NJ

Track Institutional and Insider Activities on TMBR

Follow Timber Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMBR shares.

Notify only if

Insider Trading

Get notified when an Timber Pharmaceuticals, Inc. insider buys or sells TMBR shares.

Notify only if

News

Receive news related to Timber Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TMBR